UNSPSC 51434919: Captopril/hydrochlorothiazide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434919 Captopril/hydrochlorothiazide is a Commodity code that covers specific pharmaceutical products — in this case, antihypertensive combination medications — procured by state and local emergency services and public-health systems. Recent activity under the code reflects procurement of pre-formulated medication combinations for acute clinical use. State and local issuing bodies soliciting under this code span fire departments and emergency medical services operating within county and municipal jurisdictions. The work involves supply of finished-dose medications meeting strict pharmaceutical standards, including expiration-date warranties, defect guarantees, and compliance with federal accessibility and occupational safety documentation requirements.

Activity under the code is sparse in the recent-opportunities block. The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications to support Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026, and estimated contract value of $40,000.00. The solicitation requested four specific medication line items (Labetalol HCI, Epinephrine, Adenosine, and Diltiazem) totaling 3,530 units, with one-year initial term and two one-year renewal options. The notice carried an SLBE sheltered market designation with a 5 percent bid discount capped at $10,000. No other recent opportunities are present in the source, limiting visibility into broader geographic or issuing-body patterns.